Location History:
- Rochester, NY (US) (2016 - 2020)
- Webster, NY (US) (1998 - 2023)
Company Filing History:
Years Active: 1998-2023
Title: Innovation Spotlight: Stephen D. Dertinger - Pioneering Inventor in Genotoxicity Assessment
Introduction:
Stephen D. Dertinger is a leading inventor based in Webster, NY, United States, with an impressive portfolio of 24 patents to his credit. His innovative work in the field of genotoxicity assessment has significantly contributed to advancing research and development in the biotechnology industry.
Latest Patents:
One of Stephen D. Dertinger's latest patents is the "Simplified Nuclei Analysis Platform and Biomarker Matrix that Supports Genotoxic Mode of Action Determinations." This invention introduces a simple yet effective method for evaluating free eukaryotic cell nuclei for biomarkers of DNA damage, transcription factor activation, and epigenetic modifications. The patented technology also offers valuable strategies for combining nuclear biomarkers into an endpoint matrix to uncover genotoxicants' primary mode of DNA-damaging activity.
Career Highlights:
Stephen D. Dertinger is affiliated with Litron Laboratories Ltd., a renowned company in the biotechnology sector. His contributions to the company have been invaluable, driving forward innovative solutions in genotoxicity assessment and DNA damage analysis. Dertinger's groundbreaking research has positioned him as a thought leader in the industry, renowned for his expertise and pioneering inventions.
Collaborations:
Throughout his illustrious career, Stephen D. Dertinger has collaborated closely with esteemed peers in the field of biotechnology. Notable coworkers include Steven M. Bryce and Dorothea K. Torous, who have worked alongside Dertinger in developing cutting-edge technologies and methodologies for genotoxicity assessment.
Conclusion:
In conclusion, Stephen D. Dertinger stands out as a visionary inventor whose work has revolutionized genotoxicity assessment and DNA damage analysis. His dedication to innovation and scientific excellence continues to shape the landscape of biotechnology, paving the way for novel discoveries and advancements in the field. Dertinger's valuable contributions underscore his status as a trailblazer in the industry, driving forward progress and innovation in genotoxic mode of action determinations.